Erasca (ERAS) Change in Cash (2020 - 2026)
Erasca (ERAS) reported Change in Cash of -$26.5 million for Q1 2026, down 1067.88% on a YoY basis from $2.7 million in Q1 2025, and down 842.63% quarter-over-quarter from $3.6 million in Q4 2025.
Erasca (ERAS) Change in Cash (2020 - 2026) Analysis & Trends
Erasca has reported Change in Cash for 7 years, with the latest figure at -$26.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Cash fell 1067.88% year-over-year to -$26.5 million; the trailing twelve-month figure through Mar 2026 stood at -$23.2 million (down 271.97% YoY), and the FY2025 full-year result was $6.1 million, up 123.94% from the prior year.
- Change in Cash for Q1 2026 stood at -$26.5 million, down from $3.6 million in the prior quarter.
- The five-year high for Change in Cash was $96.1 million in Q2 2024, with the low at -$134.0 million in Q2 2023.
- Historically, Change in Cash has averaged -$18.4 million across 5 years, with a median of -$16.3 million in 2024.
- Annual changes were most pronounced in 2025 — Change in Cash soared 411.95% — and 2026, when it plunged 1067.88%.
- Erasca's Change in Cash stood at $65.0 million in 2022, then slumped by 130.46% to -$19.8 million in 2023, then jumped by 94.21% to -$1.1 million in 2024, then soared by 411.95% to $3.6 million in 2025, then plunged by 842.63% to -$26.5 million in 2026.
- The last three Change in Cash figures came in at -$26.5 million (Q1 2026), $3.6 million (Q4 2025), and $4.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | Erasca | 4.16 Bn | 3.92 Bn | - | -26.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.55 Mn |
| Dec 31, 2025 | 3.58 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | -4.34 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Sep 30, 2024 | -103.92 Mn |
| Jun 30, 2024 | 96.08 Mn |
| Mar 31, 2024 | -16.35 Mn |
| Dec 31, 2023 | -19.79 Mn |
| Sep 30, 2023 | -25.93 Mn |
| Jun 30, 2023 | -133.97 Mn |
| Mar 31, 2023 | -11.46 Mn |
| Dec 31, 2022 | 64.96 Mn |
| Sep 30, 2022 | -78.75 Mn |
| Jun 30, 2022 | -35.34 Mn |
| Mar 31, 2022 | -27.14 Mn |
| Dec 31, 2021 | -85.32 Mn |
| Sep 30, 2021 | 289.42 Mn |
| Jun 30, 2021 | -13.59 Mn |